Rob A. I. de Vos
- Neurology top 0.02%
- Parkinson's Disease Mechanisms and Treatments 32
- Neurological disorders and treatments 25
- Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments 32
- Neurological disorders and treatments 25
- Cellular and Molecular Neuroscience top 0.2%
- Genetic Neurodegenerative Diseases 23
- Neuroscience and Neuropharmacology Research 10
- Sensory Systems top 0.5%
- Physiology top 0.5%
- Alzheimer's disease research and treatments 14
-
- Mitochondrial Function and Pathology 11
- Ubiquitin and proteasome pathways 7
- Nicotinic Acetylcholine Receptors Study 7
- Co-authors
- Heiko BraakKelly Del TrediciUdo RübErnst N.H. Jansen SteurEva BraakJ. BöhlE.N.H. JansenPaul G.M. Luiten
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Rob A. I. de Vos
79 papers receiving 15.4k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Neurology 10.2k
- Neurology 2.9k
- Cellular and Molecular Neuroscience 4.8k
- Sensory Systems 757
- Physiology 3.5k
Countries citing papers authored by Rob A. I. de Vos
This map shows the geographic impact of Rob A. I. de Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob A. I. de Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob A. I. de Vos more than expected).
Fields of papers citing papers by Rob A. I. de Vos
This network shows the impact of papers produced by Rob A. I. de Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob A. I. de Vos. The network helps show where Rob A. I. de Vos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rob A. I. de Vos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 17 | |
| 2 | 2009 | 36 | |
| 3 | 2007 | 28 | |
| 4 | 2007 | 415 | |
| 5 | 2006 | 125 | |
| 6 | 2006 | 65 | |
| 7 | 2005 | 27 | |
| 8 | 2004 | 90 | |
| 9 | 2004 | 128 | |
| 10 | 2003 | 31 | |
| 11 | Staging of brain pathology related to sporadic Parkinson’s diseasebreakdown → | 2002 | 7634 |
| 12 | 2001 | 27 | |
| 13 | 2000 | 81 | |
| 14 | 2000 | 1 | |
| 15 | Depression in Parkinson's disease is not accompanied by more corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus | 1998 | 8 |
| 16 | 1998 | 116 | |
| 17 | 1998 | 11 | |
| 18 | 1996 | 24 | |
| 19 | 1994 | 236 | |
| 20 | 1989 | 1 |
About Rob A. I. de Vos
Rob A. I. de Vos is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology, having authored 79 papers that have together received 15.7k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (32 papers), Neurological disorders and treatments (25 papers), Genetic Neurodegenerative Diseases (23 papers), Alzheimer's disease research and treatments (14 papers), Mitochondrial Function and Pathology (11 papers), Neuroscience and Neuropharmacology Research (10 papers), Ubiquitin and proteasome pathways (7 papers) and Nicotinic Acetylcholine Receptors Study (7 papers). The work is most often cited by research in Neurology (10.2k citations), Neurology (2.9k citations) and Cellular and Molecular Neuroscience (4.8k citations). Rob A. I. de Vos has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Heiko Braak, Kelly Del Tredici, Udo Rüb, Ernst N.H. Jansen Steur, Eva Braak, J. Böhl, E.N.H. Jansen, Paul G.M. Luiten, Estifanos Ghebremedhin and Deniz Yilmazer‐Hanke. Their work appears in journals such as Journal of Neuroscience, Biomaterials and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.